Tag: Arcellx

Arcellx, and Kite to jointly advance CART-ddBMCA for multiple myeloma

Arcellx, a US-based clinical-stage biotechnology company, and Kite, a Gilead company, are partnering to co-develop and co-commercialize the former’s CART-ddBCMA, a late-stage product candidate. CART-ddBCMA, ... Read More